Japanese drugmaker Astellas Pharma (OTCPK:ALPMY) said on Monday that the U.S. Food and Drug Administration (FDA) has declined to approve the biologics license application of its experimental gastric ...
Source LinkJapanese drugmaker Astellas Pharma (OTCPK:ALPMY) said on Monday that the U.S. Food and Drug Administration (FDA) has declined to approve the biologics license application of its experimental gastric ...
Source Link
Comments